名稱 | BCR-ABL1 H396P/BaF3 |
型號(hào) | CBP73317 |
報(bào)價(jià) | ![]() |
特點(diǎn) | BCR-ABL1 [H396P]/BaF3 |
產(chǎn)品搜索
相關(guān)文章
- LTβR信號(hào)通路誘導(dǎo)三級(jí)淋巴結(jié)構(gòu)的形成,促進(jìn)趨化因子的表達(dá)
- 【連載-Toll樣受體系列2】TLR7激動(dòng)劑藥物細(xì)胞篩選模型
- BTK細(xì)胞篩選模型
- 治療疼痛的潛力靶點(diǎn)——NGF
- 【新品上線】FGFR診斷標(biāo)準(zhǔn)品
- 科佰生物提前祝大家中秋快樂(lè),闔家團(tuán)圓!
- CNV參考品
- PIK3CA診斷標(biāo)準(zhǔn)品
- 新型冠狀病毒:用于診斷的假病毒標(biāo)準(zhǔn)品和用于藥物研發(fā)的假病毒模型
- 人類白細(xì)胞抗原HLA基因分型標(biāo)準(zhǔn)品
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73317BCR-ABL1 H396P/BaF3

- 詳細(xì)內(nèi)容
CBP73317 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [H396P]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1.WB of BCR-ABL1 [H396P]/BaF3 | |
2.Sanger of BCR-ABL1 [H396P]/BaF3 Figure 2. BCR-ABL1 [H396P]/BaF3 Figure 3. BCR-ABL1 [H396P]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 H396P Cells (C3). | |